September 2007
Worldwide Biotech;Sep2007, Vol. 19 Issue 9, p5
Trade Publication
The article reports on the exclusive licensing agreement between Tikvah Therapeutics Inc. and Academia Sinica in Taipei, Taiwan for a number of patent and patent applications for the diagnosis, methods of use and treatments of neurodegenerative disorders. Under the agreement, Tikvah Therapeutics will undertake clinical development of the neurodegenerative technology and agents, particularly spinal muscular atrophy, developed by researchers at Academia Sinica. Information on spinal muscular atrophy is presented.


Related Articles

  • Induction of full-length survival motor neuron by polyphenol botanical compounds. Sakla, Mary S.; Lorson, Christian L. // Human Genetics;Jan2008, Vol. 122 Issue 6, p635 

    The loss of survival motor neuron-1 ( SMN1) is responsible for the development of the neurodegenerative disorder spinal muscular atrophy (SMA). A nearly identical copy of SMN1 is present on the same chromosomal region called SMN2. While SMN2 encodes a normal SMN protein, the majority of...

  • Interaction between the small-nuclear-RNA cap hypermethylase and the spinal muscular atrophy protein, survival of motor neuron. Mouaikel, John; Narayanan, Usha; Verheggen, C�line; Matera, A. Gregory; Bertrad, Edouard; Tazi, jamal; Bordonn�, R�my // EMBO Reports;Jun2003, Vol. 4 Issue 6, p616 

    The biogenesis of splicfeosomal small nuclear ribonucleoproteins (snRNPs) requires the cytoplasmic assembly of the Smcore complex, followed by the hypermethylation of the small nuclear RNA (snRNA) 5'cap. Both the Sm-core complex and the snRNA trimethylguanosine cap are required for the efficient...

  • SMN Deficiency Reduces Cellular Ability to Form Stress Granules, Sensitizing Cells to Stress. Tie Zou; Xianming Yang; Pan, Danmin; Jia Huang; Sahin, Mustafa; Jianhua Zhou // Cellular & Molecular Neurobiology;May2011, Vol. 31 Issue 4, p541 

    Spinal Muscular Atrophy (SMA) is a neurodegenerative disease that is caused by deletion of the SMN (Survival of Motor Neuron) gene. The SMN protein is essential for cell survival and co-localized with TIA-1/R and G3BP, two characteristic markers of stress granules (SGs). To further study the SMN...

  • The spinal muscular atrophy mouse model, SMAΔ7, displays altered axonal transport without global neurofilament alterations. Dale, Jeffrey; Shen, Hailian; Barry, Devin; Garcia, Virginia; Rose, Ferrill; Lorson, Christian; Garcia, Michael // Acta Neuropathologica;Sep2011, Vol. 122 Issue 3, p331 

    Spinal muscular atrophy (SMA) is a neurodegenerative disease resulting from decreased levels of survival motor neuron 1 (SMN1) protein. Reduced SMN1 levels are linked to pathology at neuromuscular junctions (NMJs), which includes decreased vesicle density and organization, decreased quantal...

  • Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice. Linghua Qiu; Tao Qiao; Melissa Beers; Weijia Tan; Hongyan Wang; Bin Yang; Zuoshang Xu // Molecular Neurodegeneration;2013, Vol. 8 Issue 1, p1 

    Background: A proline-to-serine substitution at position-56 (P56S) of vesicle-associated membrane protein-associated protein B (VAPB) causes a form of dominantly inherited motor neuron disease (MND), including typical and atypical amyotrophic lateral sclerosis (ALS) and a mild late-onset spinal...

  • Channelopathies converge on TRPV4. Nilius, Bernd; Owsianik, Grzegorz // Nature Genetics;Feb2010, Vol. 42 Issue 2, p98 

    Scapuloperoneal spinal muscular atrophy and Charcot-Marie-Tooth disease type 2C are inherited neurodegenerative diseases characterized by sensory defects and muscle weakness. Three new studies demonstrate that they are allelic disorders caused by mutations in the vanilloid transient receptor...

  • Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Auer-Grumbach, Michaela; Olschewski, Andrea; Papić, Lea; Kremer, Hannie; McEntagart, Meriel E.; Uhrig, Sabine; Fischer, Carina; Fröhlich, Eleonore; Bálint, Zoltán; Bi Tang; Strohmaier, Heimo; Lochmüller, Hanns; Schlotter-Weigel, Beate; Senderek, Jan; Krebs, Angelika; Dick, Katherine J.; Petty, Richard; Longman, Cheryl; Anderson, Neil E.; Padberg, George W. // Nature Genetics;Feb2010, Vol. 42 Issue 2, p160 

    Spinal muscular atrophies (SMA, also known as hereditary motor neuropathies) and hereditary motor and sensory neuropathies (HMSN) are clinically and genetically heterogeneous disorders of the peripheral nervous system. Here we report that mutations in the TRPV4 gene cause congenital distal SMA,...

  • The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy. Pedrotti, Simona; Bielli, Pamela; Paronetto, Maria Paola; Ciccosanti, Fabiola; Fimia, Gian Maria; Stamm, Stefan; Manley, James L.; Sette, Claudio // EMBO Journal;4/1/2010, Vol. 29 Issue 7, p1235 

    Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by loss of motor neurons in patients with null mutations in the SMN1 gene. An almost identical SMN2 gene is unable to compensate for this deficiency because a single C-to-T transition at position +6 in exon-7 causes skipping of...

  • Fine-mapping and candidate gene analysis of bovine spinal muscular atrophy. Krebs, Stefan; Medugorac, Ivica; Russ, Ingolf; Ossent, Pete; Bleul, Ulrich; Schmahl, Wolfgang; Förster, Martin // Mammalian Genome;Jan2006, Vol. 17 Issue 1, p67 

    Bovine spinal muscular atrophy (SMA), an autosomal recessive neurodegenerative disease, has been mapped at moderate resolution to the distal part of Chromosome 24. In this article we confirm this location and fine-map the SMA locus to an interval of approximately 0.8 cM at the very distal end of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics